Infectious Disease Diagnostics Market Size & Share 2023 to 2032
Market Size by Product (Instruments, Reagents, kits & Consumables, Services), by Technology (Clinical Microbiology, Polymerase Chain Reaction, In Situ Hybridization, INAAT, Immunodiagnostics), by Application, by End Use & Forecast.
Report ID: GMI5597
|
Published Date: May 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Infectious Disease Diagnostics Market Size
Infectious Disease Diagnostics Market size was USD 24 billion in 2022 and will exhibit more than 5.5% CAGR from 2023-2032. Rising popularity of point-of-care diagnostic testing techniques to supplement industry growth.
Infectious Disease Diagnostics Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The increasing preference for point-of-care diagnostic testing will influence the industry expansion. Rapid results obtained from point-of-care testing are increasingly crucial for prompt diagnosis and treatment in urgent care centres, emergency rooms, and ambulances. The growing need for rapid diagnosis and treatment helps to enhance patient outcomes while catering to several illnesses or infectious diseases has made way for innovations, further driving the market share.
Limited awareness pertaining to infection control and prevention as well as personal health and hygiene, specifically in the underdeveloped nations may pose as a major barrier for the demand for infectious disease diagnostics. Numerous hospitals are facing the challenges of inadequate infrastructure, such as poor water sanitation, and hygiene facilities. Lack of training among healthcare professionals for infection control in healthcare settings, staff shortages, and ineffective compliance of hospital and patient staff with hygiene standards are other factors limiting the market size.
Infectious Disease Diagnostics Market Analysis
Infectious disease diagnostics market share from the reagents, kits & consumables segment was over USD 12 billion in 2022. This is attributed to the abundant availability of reagents, kits, and consumables for diagnosing several infectious diseases on the basis of exact targeted pathogens and conducted diagnostic tests. The growing adoption of RT-PCR in identifying RNA viruses including influenza, SARS-CoV-2, and hepatitis C will also add to the industry landscape.
Infectious disease diagnostics market from respiratory disease applications will record 6% CAGR from 2023-2032. In recent years, there has been a significant rise in the number of pathogens that cause respiratory infections include bacteria, viruses, fungi, and parasites. Chest X-rays, such as CT scans, physical exams, and laboratory tests, including PCR testing of respiratory secretions and blood are increasingly employed as diagnostic tools to treat respiratory infections. The growing prominence of these tests for determining the origin of respiratory infections and offering the best course of actions will influence the industry scenario.
North America infectious disease diagnostics market is estimated to exceed USD 17 billion by 2032 due to the surging frequency of infectious diseases and the scaling deployment of cutting-edge diagnostic technologies. The rising healthcare costs and the rapidly expanding ageing population mainly in the U.S., Canada and Mexico will also boost the development of the regional market.
Infectious Disease Diagnostics Market Share
are some of the leading infectious disease diagnostics industry market participants worldwide. These firms are actively adopting various strategies to boost their revenue sales.
Infectious Disease Diagnostics Industry News
The infectious disease diagnostics market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and volume in Units from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product
By Technology
By Application
By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →